PE Anti-Human CD31 Antibody[158-2B3]

The PE Anti-Human CD31 Antibody[158-2B3] is a highly reliable and efficient product designed for the specific detection and analysis of CD31 expression in human samples. This antibody, conjugated with phycoerythrin (PE), offers exceptional sensitivity and specificity, making it an ideal tool for various research applications.

CD31, also known as platelet endothelial cell adhesion molecule-1 (PECAM-1), is a transmembrane glycoprotein primarily expressed on endothelial cells. It plays a crucial role in mediating cell adhesion, migration, and angiogenesis. The PE Anti-Human CD31 Antibody[158-2B3] specifically recognizes the extracellular domain of CD31, enabling accurate identification and quantification of CD31-positive cells.

This antibody has been extensively validated and optimized to ensure consistent and reproducible results. It exhibits minimal cross-reactivity with other antigens, ensuring high specificity in detecting CD31 expression. The PE conjugation enhances the signal intensity, allowing for easy visualization and analysis of CD31-positive cells by flow cytometry.

The PE Anti-Human CD31 Antibody[158-2B3] is supplied in a convenient and ready-to-use format, eliminating the need for additional conjugation steps. It is provided in a stable formulation, ensuring long-term storage without compromising its performance. Each batch of this antibody undergoes rigorous quality control procedures to guarantee batch-to-batch consistency and reliability.

This antibody is an invaluable tool for researchers studying angiogenesis, vascular biology, and endothelial cell biology. Its exceptional performance and reliability make it suitable for a wide range of applications, including immunofluorescence staining, flow cytometry, and immunohistochemistry.

Choose the PE Anti-Human CD31 Antibody[158-2B3] for accurate and reliable detection of CD31 expression in human samples. With its exceptional sensitivity, specificity, and ease of use, this antibody will undoubtedly enhance your research outcomes and contribute to advancements in the field of vascular biology.